Fabrizio Conti

Pubblicazioni

Titolo Pubblicato in Anno
Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine VACCINES 2023
Application of Machine Learning Models in Systemic Lupus Erythematosus INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023
Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies REUMATISMO 2023
Janus kinase inhibitors: between prescription authorization and reimbursability REUMATISMO 2023
Organ damage in Systemic Lupus Erythematosus patients: A multifactorial phenomenon AUTOIMMUNITY REVIEWS 2023
Rheumatic Diseases Development in Patients Treated by Anti-PD1 Immune Checkpoint Inhibitors: A Single-Centre Descriptive Study LIFE 2023
Role of Lipid Rafts on LRP8 Signaling Triggered by Anti-β2-GPI Antibodies in Endothelial Cells BIOMEDICINES 2023
Clinical and histological features of patients with primary Sjögren's syndrome and autoimmune thyroiditis: a national multicentre cross-sectional study CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2023
Role of lipid rafts on LRP8 signaling triggered by anti-β2-GPI antibodies in endothelial cells BIOMEDICINES 2023
Should we vaccinate during an active rheumatic disease? AUTOIMMUNITY REVIEWS 2023
Early and late response and glucocorticoid-sparing effect of belimumab in patients with systemic lupus erythematosus with joint and skin manifestations. results from the belimumab in real life setting study-joint and skin (BeRLiSS-JS) JOURNAL OF PERSONALIZED MEDICINE 2023
Systematic literature review of real-world evidence on baricitinib for the treatment of rheumatoid arthritis RHEUMATOLOGY AND THERAPY 2023
Fragility fractures in lupus patients:. associated factors and comparison of four fracture risk assessment tools LUPUS 2023
Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib. SCIENTIFIC REPORTS 2023
Rheumatoid arthritis from easy to complex disease. from the "2022 GISEA international symposium" JOURNAL OF CLINICAL MEDICINE 2023
Organ damage in systemic lupus erythematosus patients. a multifactorial phenomenon AUTOIMMUNITY REVIEWS 2023
Adherence to therapy in people with rheumatic and musculoskeletal diseases in Italy and the role of the digital health: results of an expert Delphi consensus survey CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2023
Janus kinase inhibitors: between prescription authorization and reimbursability REUMATISMO 2023
Determining the PASS cut-off points for the FIQR, FASmod and PSD in patients with fibromyalgia. a registry-based study CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2023
Exercise-induced modulation of Interferon-signature. a therapeutic route toward management of systemic lupus erythematosus AUTOIMMUNITY REVIEWS 2023

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma